Company Profile
| Company Name | Oncolys BioPharma Inc. |
|---|---|
| Established | March 18, 2004 |
| Capital fund | ¥3,000 Million (May 31, 2022) |
| President & CEO | Yasuo Urata |
| Business Summary | Research, development, manufacturing, sale, and import and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents |
| Corporate headquarters | 4-1-28 Toranomon, Minato-ku, Tokyo 105-0001 Japan (MAP) Phone:+81-3-5472-1578 FAX:+81-3-5472-1488 |
| Branch office and Lab | Kobe Research Lab (MAP) «Office» HI-DEC 2F 6-7-4 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan Phone:+81-78-303-1380 Fax:+81-78-303-1381 «Assay Laboratory» HI-DEC 3F 6-7-4 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan |
| Oncolys USA Inc. | 343 Thornall Street, Suite 505 Edison, NJ 08837 (MAP) General Phone number: +1 732 -662-9880 President:Talia Biran |
| OPA Therapeutics Inc. | Frank Tufaro |
